The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British ...

Paradromics Inc. became the latest company developing a brain-computer interface (BCI) system to implant its technology, ...

South Korea’s pharmaceutical exports rose nearly 18% quarter-on-quarter to reach $2.56 billion in the first quarter (Q1) this year, according to the Korea Health Industry Development Institute.

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by synaptic dysfunction, neuronal loss and the accumulation of amyloid plaques and neurofibrillary tangles, ...

Epimab Biotherapeutics Inc. licensed out a development-ready KLK2/CD3 bispecific T-cell engager (TCE) for advanced prostate ...

Privately held Beckley Psytech Ltd. is to be taken over by Atai Life Sciences in an all-share deal that values the U.K.

A research team led by consultant and orthopedic surgeon Glen Liau Zi Qiang from Alexandra Hospital in Singapore developed a ...

Biopharma’s nonprofit deal and grant activity continues to settle into a post-pandemic rhythm, with both showing a sustained ...

Recludix Pharma Inc. has nominated a lead development candidate, REX-8756, an oral, selective and reversible small-molecule ...

Vantive Health LLC, formerly the kidney care business of Baxter International Inc., plans to invest $1 billion over the next ...

Amber Implants BV reported no device-related adverse events were seen in any of the patients fitted with its Vcfix spinal ...

LIN28 is a family of RNA-binding proteins that regulate stem cell biology and pluripotency and are involved in oncogenesis ...